Serzone-5HT2 will go off the market this month in Canada
November 2003
Serzone-5HT2 will go off the market this month in Canada.
Most, if not all, generic nefazodone products will follow.
So far, Health Canada hasn't mandated this. Nefazodone is associated with liver failure...liver transplants...even death.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote